Report Detail
Global Chronic Urticaria Or Hives Drug Market Insights, Forecast to 2025
- RnM2850345 |
- 01 February, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
The global Chronic Urticaria Or Hives Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Chronic Urticaria Or Hives Drug market based on company, product type, end user and key regions.
This report studies the global market size of Chronic Urticaria Or Hives Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chronic Urticaria Or Hives Drug in these regions.
This research report categorizes the global Chronic Urticaria Or Hives Drug market by top players/brands, region, type and end user. This report also studies the global Chronic Urticaria Or Hives Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
Market size by Product
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Market size by End User
Clinic
Hospital
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Chronic Urticaria Or Hives Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Chronic Urticaria Or Hives Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Chronic Urticaria Or Hives Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Chronic Urticaria Or Hives Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Chronic Urticaria Or Hives Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Chronic Urticaria Or Hives Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Chronic Urticaria Or Hives Drug Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Chronic Urticaria Or Hives Drug Market Size Growth Rate by Product
- 1.4.2 GDC-0853
- 1.4.3 GSK-2646264
- 1.4.4 BF-Derm-1
- 1.4.5 Bilastine
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Chronic Urticaria Or Hives Drug Market Size Growth Rate by End User
- 1.5.2 Clinic
- 1.5.3 Hospital
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Chronic Urticaria Or Hives Drug Market Size
- 2.1.1 Global Chronic Urticaria Or Hives Drug Revenue 2014-2025
- 2.1.2 Global Chronic Urticaria Or Hives Drug Sales 2014-2025
- 2.2 Chronic Urticaria Or Hives Drug Growth Rate by Regions
- 2.2.1 Global Chronic Urticaria Or Hives Drug Sales by Regions
- 2.2.2 Global Chronic Urticaria Or Hives Drug Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Chronic Urticaria Or Hives Drug Sales by Manufacturers
- 3.1.1 Chronic Urticaria Or Hives Drug Sales by Manufacturers
- 3.1.2 Chronic Urticaria Or Hives Drug Sales Market Share by Manufacturers
- 3.1.3 Global Chronic Urticaria Or Hives Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Chronic Urticaria Or Hives Drug Revenue by Manufacturers
- 3.2.1 Chronic Urticaria Or Hives Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Chronic Urticaria Or Hives Drug Revenue Share by Manufacturers (2014-2019)
- 3.3 Chronic Urticaria Or Hives Drug Price by Manufacturers
- 3.4 Chronic Urticaria Or Hives Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Chronic Urticaria Or Hives Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Chronic Urticaria Or Hives Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Chronic Urticaria Or Hives Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Chronic Urticaria Or Hives Drug Sales by Product
- 4.2 Global Chronic Urticaria Or Hives Drug Revenue by Product
- 4.3 Chronic Urticaria Or Hives Drug Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Chronic Urticaria Or Hives Drug Breakdown Data by End User
6 North America
- 6.1 North America Chronic Urticaria Or Hives Drug by Countries
- 6.1.1 North America Chronic Urticaria Or Hives Drug Sales by Countries
- 6.1.2 North America Chronic Urticaria Or Hives Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Chronic Urticaria Or Hives Drug by Product
- 6.3 North America Chronic Urticaria Or Hives Drug by End User
7 Europe
- 7.1 Europe Chronic Urticaria Or Hives Drug by Countries
- 7.1.1 Europe Chronic Urticaria Or Hives Drug Sales by Countries
- 7.1.2 Europe Chronic Urticaria Or Hives Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Chronic Urticaria Or Hives Drug by Product
- 7.3 Europe Chronic Urticaria Or Hives Drug by End User
8 Asia Pacific
- 8.1 Asia Pacific Chronic Urticaria Or Hives Drug by Countries
- 8.1.1 Asia Pacific Chronic Urticaria Or Hives Drug Sales by Countries
- 8.1.2 Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Chronic Urticaria Or Hives Drug by Product
- 8.3 Asia Pacific Chronic Urticaria Or Hives Drug by End User
9 Central & South America
- 9.1 Central & South America Chronic Urticaria Or Hives Drug by Countries
- 9.1.1 Central & South America Chronic Urticaria Or Hives Drug Sales by Countries
- 9.1.2 Central & South America Chronic Urticaria Or Hives Drug Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Chronic Urticaria Or Hives Drug by Product
- 9.3 Central & South America Chronic Urticaria Or Hives Drug by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Chronic Urticaria Or Hives Drug by Countries
- 10.1.1 Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Countries
- 10.1.2 Middle East and Africa Chronic Urticaria Or Hives Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Chronic Urticaria Or Hives Drug by Product
- 10.3 Middle East and Africa Chronic Urticaria Or Hives Drug by End User
11 Company Profiles
- 11.1 AstraZeneca Plc
- 11.1.1 AstraZeneca Plc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Products Offered
- 11.1.5 AstraZeneca Plc Recent Development
- 11.2 Biofrontera AG
- 11.2.1 Biofrontera AG Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Products Offered
- 11.2.5 Biofrontera AG Recent Development
- 11.3 ELORAC, Inc.
- 11.3.1 ELORAC, Inc. Company Details
- 11.3.2 Company Business Overview
- 11.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Products Offered
- 11.3.5 ELORAC, Inc. Recent Development
- 11.4 Faes Farma, SA
- 11.4.1 Faes Farma, SA Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Products Offered
- 11.4.5 Faes Farma, SA Recent Development
- 11.5 Genentech, Inc.
- 11.5.1 Genentech, Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Products Offered
- 11.5.5 Genentech, Inc. Recent Development
- 11.6 GlaxoSmithKline Plc
- 11.6.1 GlaxoSmithKline Plc Company Details
- 11.6.2 Company Business Overview
- 11.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Products Offered
- 11.6.5 GlaxoSmithKline Plc Recent Development
- 11.7 J Uriach Y Compania, S.A.
- 11.7.1 J Uriach Y Compania, S.A. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Products Offered
- 11.7.5 J Uriach Y Compania, S.A. Recent Development
- 11.8 Mabtech Limited
- 11.8.1 Mabtech Limited Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Products Offered
- 11.8.5 Mabtech Limited Recent Development
- 11.9 Merck & Co., Inc.
- 11.9.1 Merck & Co., Inc. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Products Offered
- 11.9.5 Merck & Co., Inc. Recent Development
- 11.10 Mycenax Biotech Inc.
- 11.10.1 Mycenax Biotech Inc. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Products Offered
- 11.10.5 Mycenax Biotech Inc. Recent Development
- 11.11 Novartis AG
- 11.12 Panacea Biotec Limited
12 Future Forecast
- 12.1 Chronic Urticaria Or Hives Drug Market Forecast by Regions
- 12.1.1 Global Chronic Urticaria Or Hives Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Chronic Urticaria Or Hives Drug Revenue Forecast by Regions 2019-2025
- 12.2 Chronic Urticaria Or Hives Drug Market Forecast by Product
- 12.2.1 Global Chronic Urticaria Or Hives Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Chronic Urticaria Or Hives Drug Revenue Forecast by Product 2019-2025
- 12.3 Chronic Urticaria Or Hives Drug Market Forecast by End User
- 12.4 North America Chronic Urticaria Or Hives Drug Forecast
- 12.5 Europe Chronic Urticaria Or Hives Drug Forecast
- 12.6 Asia Pacific Chronic Urticaria Or Hives Drug Forecast
- 12.7 Central & South America Chronic Urticaria Or Hives Drug Forecast
- 12.8 Middle East and Africa Chronic Urticaria Or Hives Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Chronic Urticaria Or Hives Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Chronic Urticaria Or Hives Drug . Industry analysis & Market Report on Chronic Urticaria Or Hives Drug is a syndicated market report, published as Global Chronic Urticaria Or Hives Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Chronic Urticaria Or Hives Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
